Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Lipids in Health and Disease|June 3, 2014
Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adultsBodil Bjørndal, Elin Strand, Jennifer Gjerde, et al.
BMC Cancer|June 19, 2012
Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancerLine L Haugan Moi, Marianne Hauglid Flågeng, Jennifer Gjerde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trialElton R Kisanga, Jennifer Gjerde, Aliana Guerrieri-Gonzaga, et al.
The Science of the Total Environment|October 31, 2025
Toxicological impact of dietary exposure to polypropylene microplastics in Atlantic salmon (Salmo salar)Shubham Varshney, Tanja Kögel, Robin Ørnsrud, et al.
Plos One|April 14, 2015
The active tamoxifen metabolite endoxifen (4OHNDtam) strongly down-regulates cytokeratin 6 (CK6) in MCF-7 breast cancer cellsThomas Helland, Jennifer Gjerde, Simon Dankel, et al.
Breast Cancer Research and Treatment|August 4, 2016
A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifenHarriet Johansson, Sara Gandini, Davide Serrano, et al.
The Pharmacogenomics Journal|April 11, 2019
Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancerHarriet Johansson, Valentina Aristarco, Sara Gandini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2010
Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissueLine L Haugan Moi, Marianne Hauglid Flågeng, Sara Gandini, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2011
Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivorsThomas P Ahern, Mariann Christensen, Deirdre P Cronin-Fenton, et al.
Breast Cancer Research : BCR|June 22, 2013
A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancerDavide Serrano, Matteo Lazzeroni, Sara Gandini, et al.
Pageof 3